Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Robert Flisiak and Dorota Zarebska-Michaluk.
Robert Flisiak
Connection Strength
9.234
Dorota Zarebska-Michaluk
  1. Effectiveness of Tocilizumab with and without Dexamethasone in Patients with Severe COVID-19: A Retrospective Study. J Inflamm Res. 2021; 14:3359-3366.
    View in: PubMed
    Score: 0.957
  2. Impact of Kidney Failure on the Severity of COVID-19. J Clin Med. 2021 May 10; 10(9).
    View in: PubMed
    Score: 0.944
  3. Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists as of April 26, 2021. Pol Arch Intern Med. 2021 05 25; 131(5):487-496.
    View in: PubMed
    Score: 0.942
  4. Tocilizumab Improves the Prognosis of COVID-19 in Patients with High IL-6. J Clin Med. 2021 Apr 09; 10(8).
    View in: PubMed
    Score: 0.939
  5. Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists. Annex no. 2 as of October 13, 2020. Pol Arch Intern Med. 2020 10 29; 130(10):915-918.
    View in: PubMed
    Score: 0.911
  6. Knowledge is coming so fast that a meta-analysis of COVID-19 treatment is always too late. Pol Arch Intern Med. 2020 09 30; 130(9):721-723.
    View in: PubMed
    Score: 0.906
  7. Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists. Annex no. 1 as of June 8, 2020. Pol Arch Intern Med. 2020 06 25; 130(6):557-558.
    View in: PubMed
    Score: 0.886
  8. Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists as of March 31, 2020. Pol Arch Intern Med. 2020 04 30; 130(4):352-357.
    View in: PubMed
    Score: 0.875
  9. Clinical Characteristics of Hospitalized COVID-19 Patients Who Received at Least One Dose of COVID-19 Vaccine. Vaccines (Basel). 2021 Jul 13; 9(7).
    View in: PubMed
    Score: 0.239
  10. Is elimination of HCV in 2030 realistic in Central Europe. Liver Int. 2021 06; 41 Suppl 1:56-60.
    View in: PubMed
    Score: 0.237
  11. Remdesivir-based therapy improved the recovery of patients with COVID-19 in the multicenter, real-world SARSTer study. Pol Arch Intern Med. 2021 01 29; 131(1):103-110.
    View in: PubMed
    Score: 0.230
  12. Convalescent Plasma Transfusion for the Treatment of COVID-19-Experience from Poland: A Multicenter Study. J Clin Med. 2020 Dec 24; 10(1).
    View in: PubMed
    Score: 0.230
  13. Tocilizumab for patients with severe COVID-19: a retrospective, multi-center study. Expert Rev Anti Infect Ther. 2021 01; 19(1):93-100.
    View in: PubMed
    Score: 0.224
  14. Is Interferon-Based Treatment of Viral Hepatitis C Genotype 3 Infection Still of Value in the Era of Direct-Acting Antivirals? J Interferon Cytokine Res. 2018 02; 38(2):93-100.
    View in: PubMed
    Score: 0.188
  15. Effectiveness and safety of ledipasvir/sofosbuvir±ribavirin in the treatment of HCV infection: The real-world HARVEST study. Adv Med Sci. 2017 Sep; 62(2):387-392.
    View in: PubMed
    Score: 0.179
  16. Efficacy of HCV treatment in Poland at the turn of the interferon era - the EpiTer study. Clin Exp Hepatol. 2016 Dec; 2(4):138-143.
    View in: PubMed
    Score: 0.173
  17. Prevalence of HCV genotypes in Poland - the EpiTer study. Clin Exp Hepatol. 2016 Dec; 2(4):144-148.
    View in: PubMed
    Score: 0.173
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.